INTRODUCTION
The striking association of phosphoinositide turnover with Ca2"-mobilizing agonists was first described by Michell (1975) . It was suggested that a second messenger formed at the plasma membrane coupled the external stimulus to Ca2" release from internal Ca2" stores. Specifically, inositol 1,4,5-trisphosphate (InsP3), the water-soluble product of phosphodiesteratic breakdown of phosphatidylinositol 4,5-bisphosphate, has been suggested to be the second messenger (Berridge, 1983; . Several studies in permeabilized cells, as well as in isolated microsomes (microsomal fractions), support the conclusion that InsP3 induces Ca2" release from internal stores, and these stores are identified as endoplasmic reticulum (Joseph et al., 1984; Suematsu et al., 1984; Dawson & Irvine, 1984; Burgess et al., 1984; Streb et al., 1983; Hirata et al., 1984; Thomas et al., 1984; Prentki et al., 1984) . However, very few attempts have been made to elucidate the mechanism responsible for this release. Smith et al. (1985) studied the temperature-dependence of InsP3-induced Ca2" release and suggested that InsP3 activates a Ca2" channel rather than a carrier mechanism. The Ca2" channel is activated by a ligand-binding mechanism that is independent of the metabolism of ATP or InsP3. Spat et al. (1986) Yet the Ca2" conductance activated by InsP3 requires an opposite flow of K+ as a counter-ion. However, the intimate mechanism of InsP3-induced Ca2" release is still unknown, and it is not yet clear whether InsP3 has any role in regulating the K+ channels in the brain.
In our previous study we reported the properties of InsP3-induced Ca2' release in brain microsomes (Shah et al., 1987) . In the present investigation, attempts are made to gain an insight into the mechanism of InsP3-induced Ca2' release by using a pharmacological and an iontransport approach. Our results indicate that the introduction of InsP3 into the incubation media induced an outward Ca2+ transport associated with an inward K+ transport, and this process is blocked by K+-channel blockers.
MATERIALS AND METHODS
Most chemicals and reagents used in this study were obtained either from Sigma Chemical Co., St. Louis, MO, U.S.A., or Fisher Scientific, Pittsburgh, PA, U.S.A., in the highest purity grade offered. Dantrolene was obtained from Norwich Eaton Pharmaceuticals, Norwich, NY, U.S.A., and wo-conotoxin fraction GVIA was obtained from Peninsula Laboratory, Belmont, CA, U.S.A. 45CaCl2 and 86RbCl were obtained from New England Nuclear.
Brain microsomes were prepared from male SpragueDawley rats (150-200 g) by the method previously published (Shah et al., 1987) .
Ca21 uptake and release were determined by measuring the radioactive Ca21 trapped inside the vesicles. Microsomes resuspended in buffer containing 100 mM-KCl, Abbreviations used: InsP3, inositol 1,4,5-trisphosphate; TEA, tetraethylammonium chloride, 9-TEA, tetraethylammonium chloride (propyltriethylammonium chloride). 20 mM-Hepes, 2.5 mM-MgCl2, 0.1 mM-EGTA and 101 ,#M-CaCl2, pH 7.0 (KCI medium), were preincubated in the same buffer with 0.1 ,Ci of 45Ca2+/ml (1 mg of protein/ml) at 37°C for 4 min. The calculated final free Ca21 in the solution was 5 /tM (Fabiato & Fabiato, 1979) .
The uptake of 45Ca2+ was initiated by the addition of 1.6 mM-ATP to the incubation media. After 15 min incubation (when Ca2" uptake attains a steady state), 0.5 ItM-InsP3 was added (unless otherwise stated) and 200 4al samples were removed at the specific time intervals indicated in each experiment. The reaction was terminated by the addition of 20 vol. of ice-cold reaction buffer devoid of 45Ca2' and filtered immediately by using a cell harvester M-24 B (Brandel). Filters were washed three times with the same buffer and counted for radioactivity in a Beckman LS-8100 liquid-scintillation counter.
K+ conductance with and without InsP3 was monitored by tracing radioactive 86Rb+ trapped in the microsomes. Microsomes (1 mg/ml of protein) were preincubated as described ahove in KCl medium, containing 4,Ci of 86Rb+/ml for 4 min. The reaction mixture was incubated with or without ATP (depending on the experimental requirement) for 15 min at 37 'C. After 15 min incubation, 0.5 ,uM-InsP3 was added and 200 ,1 samples were removed at the specified time intervals. Reaction was stopped by chilling the mixture with 20 vol. of ice-cold buffer without 86Rb+ and filtered immediately. Filters were washed and counted for radioactivity as described above for 45Ca2+ measurement. Protein was measured by the method of Lowry et al. (1951) , with bovine serum albumin as standard.
RESULTS AND DISCUSSION
A pharmacological approach was used to investigate the mechanism of InsP3-induced Ca2' release. The first step was to examine the effects of various kinds of blockers for known Ca21 channels, so that the kind of channel could be identified. Experiments were carried out with and without dihydropyridines (nitrenedipine and nifedipine), which strongly block L-type voltagesensitive Ca2+ channels (Janis & Triggle, 1983) .
Microsomes were incubated in KCl medium in the presence of ATP and 45Ca2" at 37 'C for 15 min. After the steady-state Ca2" uptake was attained, nifedipine (1O /M) or nitrenedipine (1O /SM) was added and the mixture incubated for another 15 min. InsP3 was then added and release was measured as described in the Materials and methods section. Neither nifedipine nor nitrenedipine had any effect on InsP3-induced Ca2" release. These results may exclude the possibility of InsP3-gated channel being an L-type Ca2" channel. Next the possibility of the InsP3-gated channel being an Ntype Ca2" channel was investigated by studying the effect of w-conotoxin fraction GVIA, a potent blocker for both L-type (dihydropyridine-sensitive) and N-type (dihydropyridine-insensitive) Ca21 channels (Reynolds et al., 1986) . For this experiment Ca2"-loaded microsomes were incubated with the drug (500 nM) for 15 min and then InsP3 was added. Equal samples were removed every 10 s and 45Ca21 was measured as described in the Materials and methods section. No significant effect of the drug was observed on InsP3-induced Ca2" release, which may indicate that the InsP3-gated channel may not be an L-or N-type voltage-sensitive Ca2" channel.
Some other non-specific Ca2l-channel blockers, e.g. verapamil (1 mM) (Ferry et al., 1984) , Ruthenium Red (which blocked InsP3-induced Ca2" release from human platelet membranes; Adunyah & Dean, 1986 ) and dantrolene (blocker for caffeine-induced Ca2l release in sarcoplasmic reticulum) were also tested. None of these agents inhibit the InsP3-induced Ca2" release. Table 1 summarizes these results.
Since none of the known Ca2"-channel blockers used in this study inhibited InsP3-induced Ca2" release, this suggests that the InsP3-gated channel may be different from Ca2" channels that have previously been described. (Armstrong, 1971 ) tetraethylammonium chloride (TEA) and 9-tetraethylammonium chloride (9-TEA) were used in this study. Microsomes were loaded with 45Ca2" by incubation in KCl buffer for 15 min in the presence of ATP, and then 1 mM-TEA or -9-TEA was added to the incubation mixture, which was incubated for another 10 min. After incubation in the presence of 1 mM-TEA or -9-TEA for 10 min, InsP3 was added and release was measured as described in the Materials and methods section. Fig. 1 shows the time course of InsP3-induced Ca2" release in the presence or absence of TEA or 9-TEA. Both TEA and 9-TEA block InsP3-induced Ca2" release significantly. Fig. 1 shows that the InsP3-induced Ca2" release was decreased to 20% by TEA, whereas it was almost completely blocked by 9-TEA. No effect of TEA or 9-TEA was found on Ca2" uptake.
These results may indicate that TEA and 9-TEA inhibit InsP3-gated Ca2"-channel opening by directly blocking these channels or by interfering with a step necessary for the channel opening, such as K+ transport.
To investigate these possibilities, we studied the effect 
